Search Results for "retail"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for retail. Results 31 to 40 of 361 total matches.

Comparison Table: Some Oral Drugs for Allergic Rhinitis (online only)

   
The Medical Letter on Drugs and Therapeutics • Mar 31, 2025  (Issue 1725)
to sales restrictions ▶ Individual retailers may have their own OTC generic products $20.006 ...
View the Comparison Table: Some Oral Drugs for Allergic Rhinitis
Med Lett Drugs Ther. 2025 Mar 31;67(1725):e55-7   doi:10.58347/tml.2025.1725b |  Show IntroductionHide Introduction

Regorafenib (Stivarga) for Metastatic Colorectal Cancer and GIST (online only)

   
The Medical Letter on Drugs and Therapeutics • Apr 29, 2013  (Issue 1415)
. www.fdbhealth.com/policies/drug-pricing-policy. Actual retail prices may vary. Regorafenib (Stivarga ...
Regorafenib (Stivarga – Bayer), a multikinase inhibitor, has been approved by the FDA for treatment of patients with metastatic colorectal cancer previously treated with multiple other regimens specified in the labeling. It has also been approved for use in treatment-refractory, locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST).
Med Lett Drugs Ther. 2013 Apr 29;55(1415):36 |  Show IntroductionHide Introduction

Crofelemer (Fulyzaq) for Antiretroviral-Induced Diarrhea

   
The Medical Letter on Drugs and Therapeutics • Jul 22, 2013  (Issue 1421)
retail prices may be higher. antiretrovirals crofelemer Diarrhea Fulyzag HIV Imodium loperamide ...
The FDA has approved crofelemer (kroe fel’ e mer; Fulyzaq – Salix), a chloride channel inhibitor derived from the red sap of the South American plant Croton lechleri, for symptomatic relief of noninfectious diarrhea in patients with HIV taking antiretroviral drugs. It is the first drug approved for relief of antiretroviral-induced diarrhea and the first oral botanical drug approved by the FDA.
Med Lett Drugs Ther. 2013 Jul 22;55(1421):59-60 |  Show IntroductionHide Introduction

FDA Requires Lower Dosing of Zolpidem

   
The Medical Letter on Drugs and Therapeutics • Jan 21, 2013  (Issue 1408)
. All rights reserved. ©2012. www.fdbhealth.com/policies/drug-pricing-policy. Actual retail prices may vary. 2 ...
On January 10, 2013, the FDA issued a news release to announce that it was requiring the manufacturers of the zolpidem-containing products Ambien, Ambien CR, Edluar and Zolpimist, which are all approved for treatment of insomnia, to lower the doses for women and to recommend in their labeling consideration of a lower dose for men. No change will be required in the dose of Intermezzo, a low-dose sublingual formulation of zolpidem for middle-of-the-night awakening, which is already recommended in a lower dose for women.
Med Lett Drugs Ther. 2013 Jan 21;55(1408):5 |  Show IntroductionHide Introduction

Ceritinib (Zykadia) for Non-Small Cell Lung Cancer

   
The Medical Letter on Drugs and Therapeutics • Jul 21, 2014  (Issue 1447)
. www.fdbhealth.com/policies/drug-pricingpolicy. Actual retail price may be higher. Zykadia Xalkori lung cancer ...
Ceritinib (Zykadia – Novartis), an oral tyrosine kinase inhibitor, has received accelerated approval from the FDA for treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib (Xalkori). It is the second tyrosine kinase inhibitor to be approved for ALK-positive metastatic NSCLC; crizotinib was the first. Translocations of the ALK gene are found in about 5% of lung cancers; they occur predominantly in nonsmokers with adenocarcinoma.
Med Lett Drugs Ther. 2014 Jul 21;56(1447):62-3 |  Show IntroductionHide Introduction

Comparison Chart: Some Drugs for Irritable Bowel Syndrome with Constipation (IBS-C) (online only)

   
The Medical Letter on Drugs and Therapeutics • Feb 03, 2025  (Issue 1721)
. Accessed January 12, 2025. Individual retailers may have their own generic products. 3. Dosage adjustments ...
View the Comparison Chart: Some Drugs for Irritable Bowel Syndrome with Constipation (IBS-C)
Med Lett Drugs Ther. 2025 Feb 3;67(1721):e1-3   doi:10.58347/tml.2025.1721e |  Show IntroductionHide Introduction

Telaprevir (Incivek) and Boceprevir (Victrelis) for Chronic Hepatitis C

   
The Medical Letter on Drugs and Therapeutics • Jul 25, 2011  (Issue 1369)
. Average retail cost of 12 weeks’ treatment with telaprevir and 24 weeks’ treatment with boceprevir ...
Telaprevir (Incivek – Vertex) and boceprevir (Victrelis – Merck) have been approved by the FDA for oral use in combination with peginterferon and ribavirin for treatment of chronic hepatitis C virus (HCV) genotype 1 infection in adults with compensated liver disease. Both telaprevir and boceprevir were developed specifically to inhibit the NS3/4A proteases that cleave HCV encoded polyproteins of the genotype 1 virus.
Med Lett Drugs Ther. 2011 Jul 25;53(1369):57-9 |  Show IntroductionHide Introduction

Ocriplasmin (Jetrea) for Vitreomacular Adhesion

   
The Medical Letter on Drugs and Therapeutics • Aug 05, 2013  (Issue 1422)
. ©2013. www.fdbhealth.com/policies/drug-pricing-policy. Actual retail price may be higher. Jetrea ...
Ocriplasmin (Jetrea – ThromboGenics) was recently approved by the FDA as an intravitreal injection for treatment of symptomatic vitreomacular adhesion. It is the first drug to be approved in the US for this indication.
Med Lett Drugs Ther. 2013 Aug 5;55(1422):63-4 |  Show IntroductionHide Introduction

Electronic Cigarettes

   
The Medical Letter on Drugs and Therapeutics • Nov 11, 2013  (Issue 1429)
available in retail stores and on the Internet, their use has been increasing over recent years, primarily ...
Electronic cigarettes, also called e-cigarettes, are advertised as a safer, more convenient, and socially acceptable alternative to smoking tobacco cigarettes. Widely available in retail stores and on the Internet, their use has been increasing over recent years, primarily among smokers, but also among non-smokers.
Med Lett Drugs Ther. 2013 Nov 11;55(1429):89-90 |  Show IntroductionHide Introduction

NovolinPen for Insulin Injection

   
The Medical Letter on Drugs and Therapeutics • Dec 30, 1988  (Issue 782)
retail), and each PenNeedle costs about 10 cents. The 150-unit Novolin cartridges cost $2.55 each ...
The NovolinPen (Squibb - Novo) is a device that uses prefilled cartridges to inject semisynthetic human insulin (Medical Letter, 25:63, 1983). Three formulations are available: regular insulin (Novolin R PenFill), NPH insulin isophane (Novolin N PenFill) and a mixture of 70% NPH and 30% regular (Novolin 70/30 PenFill). The NovolinPen is advertised as more accurate, more convenient and less expensive than conventional syringes and needles. The same device is marketed in Canada as the Novolin-Pen II (Connaught Novo). (An earlier device is also available as the Novolin-Pen in Canada and the...
Med Lett Drugs Ther. 1988 Dec 30;30(782):117-8 |  Show IntroductionHide Introduction